Moderator: Carla S. Saunders, DNP, APRN, NNP-BC, Advance Practice Coordinator, Pediatrix Medical Group, Neonatal Nurse Practitioner, East Tennessee Children’s Hospital, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board

CE Certified By: AMA,ACPE,ANCC,NAADAC,NASW,NBCC

Pregnant women with opioid use disorder often are more motivated for recovery compared to other populations. Prioritizing their care has the potential to have a substantial impact on generational addiction as well as the opioid epidemic. In this session, presenters will allow a platform for those in the trenches caring for pregnant women to share ideas, examine solutions, and show stakeholders the hardships faced. Additionally, presenters intend to impart advice, mentorship and knowledge that will urge medication assisted treatment (MAT) providers not currently caring for pregnant women to do so. Experienced high-risk pregnancy providers will describe their lessons learned while developing and instituting a MAT program for pregnant women. Presenters will demonstrate their response to barriers including: protocol development and implementation; ancillary service procurement and collaboration; education attainment and dispersal; and peripartum management.

UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Provide a platform to cultivate critical thought and dialogue among those who care for pregnant women with opioid use disorder.
- Encourage medication assisted treatment providers to care for pregnant women and increase awareness of the adversities encountered in providing care for pregnant women.
- Prevent other practitioners from reinventing the wheel in developing medication assisted treatment programs for pregnant women.